Today at #UNGA, MPP announced sublicence agreements with 11 manufacturers across 9 countries to develop generic versions of baloxavir, an influenza treatment, under our voluntary licence with Roche. A concrete step to strengthen pandemic preparedness, diversify supply and support access in LMICs. Read more: medicinespatentpool.org/news…… @Roche @SwissDevCoop @UNITAID @LaurusLabs @MSNLabs @Guilin__China @kimiafarmaind @hovid @Fidsoncares @qcil_uganda2

It happened this morning. At #WCC2026, our CEO @GNakigudde spoke at @MedsPatentPool Booth C30 on why community voices must shape access to cancer medicines. What we see in villages must shape global decisions. No access without community voice Proud to be part of this platform

Today at #WCC2026 > Join MPP at Booth C30 for a day of conversations on equitable access to cancer medicines. 💬 13:00-14:00 (GMT+8) | Booth C30 and online The MPP Community Advisory Panel in Action: Why do community voices matter for access to medicines? 🎙️ Join @SalomeMeyer1, @GNakigudde (@UWOCASOfficial), and @dejoh1 as they discuss how lived experience and community perspectives can help inform access strategies and contribute to more patient-centred approaches to healthcare. 🔗 YouTube Live: piped.video/live/n2MdJIIvkpY 🌏 16:10-16:40 (GMT+8) | Booth C30 and online MPP Explained: Expanding Access Through Voluntary Licensing (in Chinese and English) 🎙️Curious about MPP's work? This Chinese-language session will introduce MPP's model, explain how voluntary licensing works and explore how it supports access to innovative medicines in low- and middle-income countries. 🔗 YouTube Live: piped.video/live/0emBzEEbWzE… 🔗 Learn more: bit.ly/4gMCaWf #WCC2026 #Cancer #AccessToMedicines #CommunityVoices #VoluntaryLicensing #GlobalHealth @uicc

📍Today at #WCC2026 Today's highlights from MPP: 🎤 12:20-13:20 | Room S228 From innovation to access: addressing barriers to cancer medicines in low- and middle-income countries Featuring: 👉 Yehoda Martei (@Penn) 👉 Linda Sitorus 👉 Gertrude Nakigudde (@UWOCASOfficial) 👉 Giulia Segafredo (@MedsPatentPool) 👉 Pat Garcia-Gonzalez (@TheMaxFoundation) Moderated by: 👉 @Stellabialous 👉 @SalomeMeyer1 🤝 Visit us at Booth C30 to discuss: ✅ Access to cancer medicines ✅ Voluntary licensing ✅ Partnerships supporting access in LMICs ✅ MPP's work in non-communicable diseases 💬 Don't miss tomorrow's booth mini-sessions: ⏰ 13:00-14:00 The MPP Community Advisory Panel in Action ⏰ 16:10-16:40 MPP Explained: Expanding Access Through Voluntary Licensing (in Chinese) 🔗 Learn more: bit.ly/4gMCaWf #WCC2026 #Cancer #AccessToMedicines #GlobalHealth @uicc @MedsPatentPool

The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat. Today at #DevexUNGA81, our key partners @IPPSecretariat @DNDi @CEPIvaccines @UNITAID @MedsPatentPool discussed practical ways to turn that goal into readiness. #DiagnosisForAll

As we mark #WorldCMLDay, MPP is pleased to join @themaxfndn at the Max Global Experience in the Philippines 🇵🇭. The Philippines is among the countries beginning to benefit from MPP-enabled generic nilotinib through MPP's licence with Novartis. Partnerships matter because innovation only has impact when it reaches those who need it. 🔗 Nilotinib licence medicinespatentpool.org/lice… #WCMLD26 #CML #Cancer

Today, we join the global health community in mourning the passing of Paulo Roberto Teixeira, a pioneering public health leader, tireless advocate for human rights and universal access to treatment, and a founding board member of the Medicines Patent Pool. A central figure in #Brazil's response to HIV/AIDS, Paulo helped shape some of the principles that continue to guide the global fight against HIV today: the right to health, community engagement, access to prevention and treatment, and the conviction that scientific advances must reach everyone, regardless of where they live. He later brought this vision to the global stage through his work with @WHO and other international initiatives to expand access to antiretroviral therapy. MPP benefited greatly from Paulo's wisdom, leadership and unwavering commitment to health equity from our earliest days. His belief that access to medicines is a matter of dignity and social justice remains at the heart of our mission. We extend our deepest condolences to his family, friends, colleagues and the many people around the world whose lives were touched by his work. His legacy will continue to inspire the fight for equitable access to health technologies for all. gov.br/aids/pt-br/assuntos/n…

Ahead of #WCC2026 in Hong Kong, Dr @ymartei shares a powerful message: “Innovation matters, but access is the measure of success.” Read her story on bridging the cancer care gap and join Dr Martei and MPP at #WCC2026 on 24 September. 🔗 medicinespatentpool.org/stor… #CancerEquity #AccessToMedicines